Clinical Study
Stability of Facial Affective Expressions in Schizophrenia
Table 1
Patient characteristics.
| Gender | Age | Psychosis diagnosed | Schizophrenia diagnosed | Type of schizophrenia | Medication interv. A1, B1, C1 | Medication interview A2 |
| M | 27 | 1992 | 1997 | Paranoid 295.30 | Risperidone | Risperidone | M | 40 | 1987 | 1989 | Paranoid 295.30 | Olanzapine | Risperidone | M | 32 | 1991 | 2000 | Undiff. 295.90 | Perphenazine | Perphenazine | M | 52 | 1967 | 1971 | Paranoid 295.30 | Zuclopenthixol | Zuclopenthixol | M | 36 | 1994 | 1994 | Paranoid 295.30 | Olanzapine | Olanzapine | F | 48 | 1985 | 1985 | Paranoid 295.30 | Zuclopenthixol | Zuclopenthixol | F | 52 | 1972 | 1982 | Paranoid 295.30 | Ziprasidone | None | M | 27 | 1998 | 1998 | Catatonic 295.20 | Olanzapine | Olanzapine |
|
|